Voltar
Revisão Acesso aberto Produção Nacional Revisado por pares
BIBTEX RIS

Advanced MR Techniques for Preoperative Glioma Characterization: Part 2

2023; Wiley; Volume: 57; Issue: 6 Linguagem: Inglês

10.1002/jmri.28663

ISSN

1522-2586

Autores

Gilbert Hangel, Bárbara Schmitz‐Abecassis, Nico Sollmann, Joana Pinto, Fatemehsadat Arzanforoosh, Frederik Barkhof, Thomas C. Booth, Marta Calvo‐Imirizaldu, Guilherme de Souza e Cassia, Marek Chmelík, Patricia Clement, Ece Ercan, María A. Fernández‐Seara, Julia Furtner, Elies Fuster‐García, Matthew Grech‐Sollars, Nazmiye Tugay Guven, Gökçe Hale Hatay, Golestan Karami, Vera C. Keil, Mina Kim, Johan A F Koekkoek, Simran Kukran, Laura Mancini, Ruben Emanuel Nechifor, Alpay Özcan, Esin Öztürk-Işık, Şenol Pişkin, Kathleen M. Schmainda, Siri Fløgstad Svensson, Chih‐Hsien Tseng, Saritha Unnikrishnan, Frans M. Vos, Esther A. H. Warnert, Moss Zhao, Radim Jančálek, Teresa Nunes, Lydiane Hirschler, Marion Smits, Jan Petr, Kyrre E. Emblem,

Tópico(s)

Advanced MRI Techniques and Applications

Resumo

Preoperative clinical MRI protocols for gliomas, brain tumors with dismal outcomes due to their infiltrative properties, still rely on conventional structural MRI, which does not deliver information on tumor genotype and is limited in the delineation of diffuse gliomas. The GliMR COST action wants to raise awareness about the state of the art of advanced MRI techniques in gliomas and their possible clinical translation. This review describes current methods, limits, and applications of advanced MRI for the preoperative assessment of glioma, summarizing the level of clinical validation of different techniques. In this second part, we review magnetic resonance spectroscopy (MRS), chemical exchange saturation transfer (CEST), susceptibility-weighted imaging (SWI), MRI-PET, MR elastography (MRE), and MR-based radiomics applications. The first part of this review addresses dynamic susceptibility contrast (DSC) and dynamic contrast-enhanced (DCE) MRI, arterial spin labeling (ASL), diffusion-weighted MRI, vessel imaging, and magnetic resonance fingerprinting (MRF). EVIDENCE LEVEL: 3. TECHNICAL EFFICACY: Stage 2.

Referência(s)